Show simple item record

dc.contributor.authorPatterson, Jesse C
dc.contributor.authorJoughin, Brian Alan
dc.contributor.authorVan De Kooij, Lambertus W.
dc.contributor.authorLim, Daniel Cham-Chin
dc.contributor.authorYaffe, Michael B
dc.contributor.authorLauffenburger, Douglas A
dc.date.accessioned2020-05-15T14:07:45Z
dc.date.available2020-05-15T14:07:45Z
dc.date.issued2019-02
dc.identifier.issn2405-4720
dc.identifier.issn2405-4712
dc.identifier.urihttps://hdl.handle.net/1721.1/125262
dc.description.abstractAlthough elevated levels of reactive oxygen species (ROS) have been observed in cancer cells and cancer cells aberrantly proliferate, it is not known whether the level of reactive oxygen species and the accumulation of oxidative damage to macromolecules vary across the cell cycle. Here, we measure the prevalence of reactive oxygen species and of biomolecule oxidation across the cell cycle in freely cycling cancer cells. We report that reactive oxygen species vary during the cell cycle and peak in mitosis, resulting in mitotic accumulation of oxidized protein cysteine residues. Prolonged mitotic arrest further increased the levels of ROS and the abundance of oxidatively damaged biomolecules, including cysteine-sulfenic-acid-containing proteins and 8-oxoguanine. These finding suggest that mitotic arrest agents may enhance the effects of ROS-dependent anticancer therapies. We studied connections between ROS and the cell cycle in unsynchronized cancer cells and using multiple independent assays found that ROS and oxidative damage to biomolecules are highest in mitosis and can be further enhanced by mitotic arrest.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R01-GM104047)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R01-ES015339)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R35-ES028374)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant U54-CA112967)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant U54-CA217377)en_US
dc.description.sponsorshipUnited States. Department of Defense. Peer-Reviewed Medical Research Program (Contract W81XWH-16-1-0464)en_US
dc.description.sponsorshipKoch Institute Support Grant (P30-CA14051)en_US
dc.description.sponsorshipCenter for Environmental Health and Injury Control (U.S.) (Support Grant P30-ES002109)en_US
dc.language.isoen
dc.publisherElsevier BVen_US
dc.relation.isversionof10.1016/J.CELS.2019.01.005en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleROS and Oxidative Stress Are Elevated in Mitosis during Asynchronous Cell Cycle Progression and Are Exacerbated by Mitotic Arresten_US
dc.typeArticleen_US
dc.identifier.citationPatterson, Jesse C. et al. “ROS and Oxidative Stress Are Elevated in Mitosis during Asynchronous Cell Cycle Progression and Are Exacerbated by Mitotic Arrest.” Cell systems (2019): 163-167.e2 © 2019 The Author(s)en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalCell systemsen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-03-04T14:02:35Z
dspace.date.submission2020-03-04T14:02:37Z
mit.journal.volume8en_US
mit.journal.issue2en_US
mit.licensePUBLISHER_CC
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record